RE:odds of developing a drug to commercial stage 5000-1I was impressed with the 60 product launches at one point too very early on. I thought that may have been why they paid such a huge amount for Amco. Alot has come to light since then though. By the sounds of what has been uncovered in the Times investigation, the R&D department consists of a razor blade for peeling off old labels and a printer for putting on new ones! I'm suprised a picture of a razor blade and printer haven't shown up on twitter from Bagholder Quotes with a caption saying "Concordia Research & Development Dept" lol
Genious while it lasted. Strip the brand name, launch a "new" generic to avoid price controls, jack the price. Looks like the new bill introduced will put an end to that game though.
juniorbullalive wrote: the discovery stage to pharmacy shelves is extremely rare. Medscape pegs the ratio of researched drugs to eventually approved therapies at between 5,000-to-1 and 10,000-to-1. However, if a drug manages to gain FDA approval, the cumulative direct and indirect expenses are huge.
Read more at https://www.stockhouse.com/companies/bullboard#QCbh6283hFbS6jcQ.99